Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?-Reference-Cited by-同舟云学术

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?

Published:2011-04-09 Issue:2 Volume:5 Page:129-140
ISSN:1970-5557
Container-title:Oncology Reviews
language:en
Short-container-title:Oncol Rev

Author:

Chintala Lakshmi,Vaka Susmitha,Baranda Joaquina,Williamson Stephen K.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1007/s12156-011-0074-3

Reference80 articles.

1. Heidelberger C, Chaudhuri N, Danenberg P et al (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179:663–666

2. Rich TA (1997) Irradiation plus 5-fluorouracil: cellular mechanisms of action and treatment schedules. Semin Radiat Oncol 7:267–273

3. Smalley S, Kimler B, Evans R et al (1992) Heterogeneity of 5-fluorouracil radiosensitivity modulation in cultured mammalian cell lines. Int J Radiat Oncol Biol Phys 24:519–525

4. Drewinko B, Yang LY (1985) Cellular basis for the inefficacy of 5-FU in human colon carcinoma. Cancer Treat Rep 69:1391–1398

5. Calabro-Jones PM, Byfield JE, Ward JF et al (1982) Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro. Cancer Res 42:4413–4420

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parecoxib and 5-Fluorouracil Synergistically Inhibit EMT and Subsequent Metastasis in Colorectal Cancer by Targeting PI3K/Akt/NF-κB Signaling;Biomedicines;2024-07-09

2. 5-Fluorouracil for colorectal cancer: mechanism of action and metabolism;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2024-06

3. Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia;Supportive Care in Cancer;2024-05-14

4. Fluorinated Organic Polymers for Cancer Drug Delivery;Advanced Materials;2024-05-08

5. Hand-Foot Syndrome in Cancer Patients on Capecitabine: Examining Prevalence, Impacts, and Associated Risk Factors at a Cancer Centre in Malaysia;2023-12-08